Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
When it comes to COVID-19 detection, time is critical. This week, Diagnostic Imaging speaks with the leadership of RADLogics about their current artificial intelligence (AI) system that is designed to streamline workflow. CEO Moshe Becker shares not only the benefits of the system for radiologists, but also the impact on patient care. In addition, he also addresses what makes this AI system different from others in light of a new study that calls the efficacy and accuracy of COVID-19-related machine learning into questions. Look for the interview later this week.
For more COVID-19 AI coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Recent research has shed a great deal of light on the role of the blood-brain barrier in brain aging diseases. This week, new investigative findings will be published about the impact of having a faulty blood brain barrier and how it might affect the brain. Look for details later this week.
For more coverage of the blood brain barrier, click here.
While tuberculosis is rare in the United States, that isn’t necessarily the case around the world. And, individuals who have active infections pose a dangerous risk to those around them. In a study to-be-published later this week, investigators take a deeper look at how the use of chest X-ray or chest CT allow for more timely screenings and diagnosis. Look for the story later this week.
For additional tuberculosis coverage, click here.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.